Issued Patents All Time
Showing 26–50 of 81 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6316031 | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer | Benjamin Oshlack, Frank Pedi, Jr. | 2001-11-13 |
| 6310205 | Hypoxathine compounds | Peter Hofer, David Cavalla | 2001-10-30 |
| 6306438 | Stabilized sustained release tramadol formulations | Benjamin Oshlack, Hua-Pin Huang, Paul Goldenheim | 2001-10-23 |
| 6294195 | Orally administrable opioid formulations having extended duration of effect | Benjamin Oshlack | 2001-09-25 |
| 6294541 | Purine derivatives having phosphodiesterase IV inhibition activity | David Cavalla, Peter Hofer, Andre Gehrig, Peter Wintergerst | 2001-09-25 |
| 6268373 | Trisubstituted thioxanthines | David Cavalla, Peter Hofer | 2001-07-31 |
| 6261599 | Melt-extruded orally administrable opioid formulations | Benjamin Oshlack, Hua-Pin Huang, David Sackler | 2001-07-17 |
| 6248769 | Phenyl-triazole compounds for PDE-IV inhibition | David Cavalla, Lloyd J. Dolby, Richard William Frith | 2001-06-19 |
| 6248345 | Prolonged anesthesia in joints and body spaces | Paul Goldenheim, Peter Lacouture, Donna Donigi-Gale, Richard Sackler | 2001-06-19 |
| 6248746 | 3-(arylalkyl) xanthines | David Cavalla, Peter Hofer | 2001-06-19 |
| 6228859 | Purine derivatives having phosphodiesterase IV inhibition activity | David Cavalla, Peter Hofer, Andre Gehrig, Peter Wintergerst | 2001-05-08 |
| 6211367 | Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity | David Cavalla, Peter Hofer | 2001-04-03 |
| 6210714 | Immediate release tablet cores of acetaminophen having sustained-release coating | Benjamin Oshlack | 2001-04-03 |
| 6166041 | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma | David Cavalla, John William Frank Whitehead, Lesley Walton, Andrew C. Mansfield | 2000-12-26 |
| 6153630 | Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same | David Cavalla, Lloyd J. Dolby | 2000-11-28 |
| 6143353 | Controlled release formulations coated with aqueous dispersions of acrylic polymers | Benjamin Oshlack, Frank Pedi, Jr. | 2000-11-07 |
| 6129933 | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer | Benjamin Oshlack, Frank Pedi, Jr. | 2000-10-10 |
| 6103261 | Opioid formulations having extended controlled release | Benjamin Oshlack, Frank Pedi, Jr. | 2000-08-15 |
| 6103749 | Aryl imidazole compounds having phosphodiesterase IV inhibitory activity | David Cavalla, Lloyd J. Dolby, Richard William Frith | 2000-08-15 |
| 6090816 | Aryl thioxanthines | David Cavalla, Peter Hofer | 2000-07-18 |
| 6075016 | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity | David Cavalla, Peter Hofer, Andre Gehrig, Peter Wintergerst | 2000-06-13 |
| 6066641 | Aryl thioxanthines | David Cavalla, Peter Hofer | 2000-05-23 |
| 6057445 | Purine compounds having PDE IV inhibitory activity and methods of synthesis | David Cavalla, Peter Hofer | 2000-05-02 |
| 6040447 | Purine compounds having PDE IV inhibitory activity and methods of synthesis | David Cavalla, Peter Hofer | 2000-03-21 |
| 6037470 | Purine compounds having PDE IV inhibitory activity and methods of synthesis | David Cavalla, Peter Hofer | 2000-03-14 |